Newsletter | December 1, 2023

12.01.23 -- Industry Outlook 2024

FEATURED ARTICLES

Executive Outlook: Converting Innovative Science Into Predictable Returns

Executives at Big Pharma and small biotech will be rewarded in 2024 if they can find new ways to develop and commercialize drugs in the context of an unforgiving investment, payer, and regulatory landscape.

Finance And Funding: Anticipating Improvement, Planning For Uncertainty

Executives responding to this year’s finance and funding outlook questions are optimistic about the potential for a turnaround in 2024.

Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place

Biopharmaceutical companies can’t afford to halt production lines due to manufacturing violations next year. Manufacturing and supply chain processes will require fresh thinking and flexibility in 2024.

INDUSTRY INSIGHTS

Is Your Medical Information Website Better Than Dr. Google?

Online medical misinformation abounds, and pharmaceutical companies need dedicated MA resources to communicate with HCPs and consumers to ensure the material they find is up-to-date and accurate.

CDMO Outsourcing Trends And Benefits In Biologics Manufacturing

The demand for biologics is projected to rise over the next decade. Explore the benefits of partnering with a CDMO as you aim to bring your drug to market.

Effects Of The Ongoing Pandemic On Bupivacaine HCI Supply

Throughout the pandemic, painkiller and sedative demands spiked. Drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of Bupivacaine HCl and other essential drugs.

DIGITAL EDITION

December 2023 Digital Edition

Inside you will find more on:

  • Clinical Trial Site Challenges
  • Real-World Data
  • Outsourcing
  • Next Generation Vectors

View the digital edition.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: